Soccio, P.; Moriondo, G.; d’Alessandro, M.; Scioscia, G.; Bergantini, L.; Gangi, S.; Tondo, P.; Foschino Barbaro, M.P.; Cameli, P.; Bargagli, E.;
et al. Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis. Biomedicines 2024, 12, 269.
https://doi.org/10.3390/biomedicines12020269
AMA Style
Soccio P, Moriondo G, d’Alessandro M, Scioscia G, Bergantini L, Gangi S, Tondo P, Foschino Barbaro MP, Cameli P, Bargagli E,
et al. Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis. Biomedicines. 2024; 12(2):269.
https://doi.org/10.3390/biomedicines12020269
Chicago/Turabian Style
Soccio, Piera, Giorgia Moriondo, Miriana d’Alessandro, Giulia Scioscia, Laura Bergantini, Sara Gangi, Pasquale Tondo, Maria Pia Foschino Barbaro, Paolo Cameli, Elena Bargagli,
and et al. 2024. "Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis" Biomedicines 12, no. 2: 269.
https://doi.org/10.3390/biomedicines12020269
APA Style
Soccio, P., Moriondo, G., d’Alessandro, M., Scioscia, G., Bergantini, L., Gangi, S., Tondo, P., Foschino Barbaro, M. P., Cameli, P., Bargagli, E., & Lacedonia, D.
(2024). Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis. Biomedicines, 12(2), 269.
https://doi.org/10.3390/biomedicines12020269